跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule
Approved
STANDARD
MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule
Stada Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fed9873e9938dd80
Company
Stada Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
fed9873e9938dd80
Product Name
MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule
Artg Id
142093
Artg Name
MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule
Sponsor
Stada Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/stada-pharmaceuticals-australia-pty-limited
Artg Date
2008-01-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/502d9dba92da781794ba9933445d3c2c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e3b71d545fb4c8f2af48049db7d64a09.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fed9873e9938dd80
Type
Standard
Back to TGA Approvals